Synopsis
Vectibix is not indicated for the treatment of patients with mCRC for whom RAS mutation status is unknown. Vectibix is not indicated for the treatment of patients with mCRC for whom RAS mutation status is unknown.
Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.
Read the full story at FDA: drugs ↗
